(Q24247394)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14973977%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

review article

1 reference

title

Interventions for treating oral candidiasis for patients with cancer receiving treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14973977%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference

1 reference

O B Eden

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14973977%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14973977%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

24 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14973977%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14973977%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

page(s)

CD001972

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14973977%20AND%20SRC:MED&resulttype=core&format=json

Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature

24 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB2

Ketoconazole and Candidiasis: A Controlled Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB2

Therapy for oropharyngeal candidiasis in the immunocompromised host: a randomized double-blind study of fluconazole vs. ketoconazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB2

Amphotericin B versus amphotericin B plus 5-flucytosine: Poor results in the treatment of proven systemic mycoses in neutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB2

7 January 2021

Clotrimazole treatment of oral candidiasis in patients with neoplastic disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB2

7 January 2021

Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB2

7 January 2021

A comparative study of the efficacy of fluconazole and amphotericin B in the treatment of oropharyngeal candidosis in patients undergoing radiotherapy for head and neck tumours

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB2

7 January 2021

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB2

7 January 2021

Comparison of amphotericin B lipid complex (ABLC) vs. ambisome in the treatment of suspected or documented fungal infections in patients with leukemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD001972.PUB2

7 January 2021

10.1002/14651858.CD001972.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14973977%20AND%20SRC:MED&resulttype=core&format=json

24 November 2019

1 reference